Whey protein and blood sugar in people with prediabetes or type 2 diabetes
Tests whey protein drinks against placebo for blood sugar in adults with prediabetes.
Key facts
- Who runs it
- University of Arkansas
- Where
- Little Rock, United StatesSee the site
- Trial code
- Registry title
- Whey Protein Ingestion and Glucose Control in Pre- and Post Diabetic Individuals
- Status
- Recruiting
- People taking part
- 40 people, planned
- Started
- 15 Jan 2025
- Expected to end
- 1 Mar 2027
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- Whey Protein Isolate Crossover
- Placebo
- Record updated
- 6 April 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 50 to 70 with prediabetes or type 2 diabetes. It tests whey protein taken twice a day and its effect on blood sugar and insulin.
- Age
- 50 to 70 years
- Sex
- Men and women
- Disease stage
- Prediabetes or diabetes: HbA1c 5.7-6.4% (39–46 mmol/mol) or 6.5% to 7.5%, or fasting glucose of 100 mg/dL (5.6 mmol/L) or more. Body mass index 25-45 kg/m2.
- Earlier treatment
- People cannot join if they take insulin injections, GLP/GIP injections or other appetite suppressants, or take androgen, anabolic or corticosteroid medicines.
- Biomarker or test result
- HbA1c 5.7-6.4% (39–46 mmol/mol) or 6.5% to 7.5%, or fasting glucose of 100 mg/dL (5.6 mmol/L) or more. COVID-19 negative and/or without symptoms.
Main reasons for not taking part
- Does not eat dairy protein, or has lactose intolerance
- Takes insulin or GLP/GIP injections or appetite suppressants
- Pregnant or breastfeeding
- Had stomach or bowel bypass or reduction surgery
- Has a long-lasting inflammatory disease such as lupus or Crohn's disease
The registry criteria, word for word
Show all 21 criteriaShow less
Who can take part
- Males and females ages 50-70 years
- Body mass index between 25-45 kg/m2
- Capable of providing informed consent
- COVID-19 negative and/or asymptomatic
- Willing to abstain from drinking alcohol or consuming marijuana and CBD products during the 7-day study meal period on two occasions
- HbA1c: 5.7-6.4% or 6.5% to 7.5% or fasting glucose ≥100 mg/dL
Who cannot take part
- History of chemotherapy or radiation therapy for cancer in the 6 months prior to enrollment
- Currently receiving androgen (e.g., testosterone) or anabolic (e.g., GH, IGF-I) therapy
- Currently using corticosteroid medications (cortisone, hydrocortisone, prednisone, etc.)
- History of gastrointestinal bypass/reduction surgery
- History of a chronic inflammatory disease (e.g. Lupus, Crohn's disease)
- Any medical condition or medication that the PI or clinical study staff finds contradictory to this study
- Hemoglobin <10g/dL at screening
- Subject who does not/will not eat dairy protein sources
- Subjects taking exogenous insulin injections or GLP /GIP injections or other appetite suppressants
- Unwilling to keep a detailed 7 day food journal on two occasions
- Unwilling to wear a CGM for 7 days on two occasions and share the data with the research team
- Lactose intolerance
- Pregnant or lactating individuals
- Unwilling to avoid using protein or amino-acid supplements during participation
- Unwilling to fast overnight
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 50 and 70 years old?
Where in United States
- University of Arkansas for Medical SciencesLittle Rock, United StatesContact: Samantha Seale, MSTaking people
About the trial
What the trial wants to find out
To examine the effects of twice daily whey protein consumption on blood glucose and insulin in pre-diabetic and diabetic individuals
The 2 groups in the trial
- Whey Protein SupplementationTreatment being tested
Crossover study
Treatment: Whey Protein Isolate Crossover
- Placebo SupplementationPlacebo, for comparison
Crossover study
Treatment: Placebo
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Whey Protein Ingestion and Glucose Control in Pre- and Post Diabetic Individuals
- Plain-language title
- Whey protein and blood sugar in people with prediabetes or type 2 diabetesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT06694155, who can take part
- Record updated
- 6 April 2026